News & Events

Getz Pharma unveils SAFE-PAK study, Pakistan’s first randomized controlled clinical trial on Empagliflozin

Getz Pharma conducted the SAFE-PAK study, Pakistan's first randomized controlled clinical trial to test the safety and efficacy of Empagliflozin - a medicine used to treat type 2 diabetes. Getz Pharma unveiled the promising results of the SAFE-PAK study with the leading health care fraternity at the 7th Mid-Summer Endocrine Updates, hosted by the Pakistan Endocrine Society.

Getz Pharma launches Pakistan’s first Metabesity Guideline in collaboration with leading medical societies of the country

As a research-driven pharmaceutical company, Getz Pharma takes an active role in supporting advanced scientific studies that can help patients and healthcare professionals in dealing with life-threatening diseases. This time, Getz Pharma is proud to launch Pakistan’s first Metabesity Guideline in collaboration with leading medical societies of Pakistan.

IBA panel discussion “After COVID: What have we learnt?”

On June 23rd, 2021, the Institute of Business Administration (IBA) held a discussion under their ‘CEO Forum’- a platform where different business leaders gather to present their views on current and impending topics. This time, the topic under discussion was: “After COVID: What have we learnt?”. The panelists at this session included Khalid Mahmood, Managing Director and CEO, Getz Pharma, Dinshaw Avari, Executive Director of Avari Hotels, Huma Adnan, Creative Director of FNKAsia and Craft Stories, Kashan Hasan, CEO Reckitt Pakistan and Azhar Abbas, Managing Director of Geo News. The session was moderated by Akbar Zaidi, Executive Director, IBA Karachi.

Getz Pharma Makes Environmental History

Getz Pharma announced that its new manufacturing facility, named Astola, has been awarded the First LEED Platinum Certification for a pharmaceutical plant in South Asia, by the U.S. Green Building Council.